Finemedix Co., Ltd. (KOSDAQ:387570)
South Korea · Delayed Price · Currency is KRW 7,730.00
-240.00 (-3.01%)
At close: Aug 28, 2025
Finemedix Revenue
Finemedix had revenue of 2.46B KRW in the quarter ending June 30, 2025, with 26.19% growth. This brings the company's revenue in the last twelve months to 10.60B, up 11.73% year-over-year. In the year 2024, Finemedix had annual revenue of 9.96B, down -1.91%.
Revenue (ttm)
10.60B
Revenue Growth
+11.73%
P/S Ratio
3.96
Revenue / Employee
151.38M
Employees
70
Market Cap
41.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.96B | -193.73M | -1.91% |
| Dec 31, 2023 | 10.15B | 2.01B | 24.71% |
| Dec 31, 2022 | 8.14B | 888.41M | 12.25% |
| Dec 31, 2021 | 7.25B | -656.61M | -8.30% |
| Dec 31, 2020 | 7.91B | 299.80M | 3.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hyundai Motor Company | 182.25T |
| Hanwha Aerospace | 19.25T |
| HD Hyundai Heavy Industries | 15.58T |
| Kia Corporation | 111.04T |